Supporting these observations, it has recently been postulated that SDS22, a regulatory subunit of PP1, inhibits the growth of breast cancer cells by inducing apoptosis, demonstrating the molecular mechanism by which PP1 negatively regulates the AKT pathway [133]. This evidence concerns the gene PPA1 and breast carcinoma.